The industry is ever-changing and with the advent of innovative therapeutics taking hold, regulators and industry leaders are prompted to take proactive approaches to get treatments to patients faster.
This event will explore novel and developing technologies that tackle the most pressing challenges and push innovation in the world of aseptic processing and sterile manufacturing.
Contamination control measures in GMP combine technical and organizational/ procedural control measures following Quality Risk management principles and when applied for processing specific sterile products or advanced therapies require to be defined in a Contamination control strategy; CCS (Annex 1 requirement).